ANTIBIOTIC-PROPHYLAXIS IN ESOPHAGEAL SURGERY

被引:4
作者
SHARPE, DAC
RENWICK, P
MATHEWS, KHR
MOGHISSI, K
机构
[1] North Humberside Cardiothoracic Centre, Castle Hill Hospital, Cottingham, North Humberside
关键词
ESOPHAGUS; SURGERY; INFECTION; ANTIBIOTICS;
D O I
10.1016/1010-7940(92)90009-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A prospective randomised study to assess the efficacy of antibiotic prophylaxis in oesophageal surgery was performed, in which 226 consecutive patients (113 male and 113 female, age range 24-86 years, mean age 65 years) were included. The study patients were in two groups: group 1, in which the upper alimentary tract was opened during surgery, and group 2, in which it was not. The group 1 patients (n = 129) were randomised to one of three antibiotic prophylaxis regimes prior to surgery. Group A patients (n = 42) were treated with cefuroxime (CFX) 1.5 g at induction of anaesthesia and then CFX 750 mg b.i.d. for 4 days. Group B patients (n = 46) were treated with CFX 1.5 g and metronidazole (MTR) 1.0 g at induction of anaesthesia, then CFX 750 mg b.i.d. and MTR 500 mg qds for 4 days. Group C (n = 41) treated with CFX 1.5 g and MTR 1.0 g at the induction of anaesthesia. Group 2 (n = 97) was divided into two groups, group D (n = 47) treated with CFX 1.5 g on induction of anaesthesia alone. Group E (n = 50) treated with CFX 1.5 g on induction of anaesthesia then CFX 750 mg bd for 2 days. We found a significantly higher incidence of infective complications in subgroup C (43.9%) and subgroup A (21.4%) compared to subgroup B (8.6%). This difference was most marked in patients undergoing oesophagectomy. We found significantly higher infection rates of infective complications in subgroup D (10.6%) as compared to subgroup E (2%).
引用
收藏
页码:561 / 564
页数:4
相关论文
共 15 条
[1]  
Churchill E.D., Sweet R.H., Transthoracic resection of tumours of the stomach and oesophagus, Ann Surg, 115, pp. 897-917, (1942)
[2]  
Condon R.E., Bartlett J.G., Greenlee H., Schulte W.J., Ochi S., Abbe R., Caruana J.A., Gordon H.E., Horsley J.S., Irvan G., Johnson W., Jordan P., Keitzer W.S., Lempeke R., Read R.C., Schumer W., Schwartz M., Storm F.K., Vetto R.M., Efficacy of oral and systemic antibiotics prophylaxis in colorectal surgery, Arch Surg, 118, (1983)
[3]  
Earlam R.J., Cunha-Melo J.R., Oesophageal squamous cell carcinoma. 1. A critical review of surgery, Br J Surg, 67, pp. 381-390, (1980)
[4]  
Edmondson H.T., Rissing J.P., Prophylactic antibiotics in colon surgery, Arch Surg, 118, (1983)
[5]  
Ellis F.H., Olsen A.M., Schlegel J.F., Code C.F., Surgical treatment of oesophageal hypermotility disturbances, JAMA, 188, pp. 862-866, (1964)
[6]  
Fan S.T., Lau W.Y., Yip W.C., Poon G.P., Yeung C., Lam W.K., Wong K.K., Prediction of post operative pulmonary complications in oesophogastric cancer surgery, Br J Surg, 74, (1987)
[7]  
Galanduik S., Hermann R.E., Gassman J.J., Cosgrove D.M., Cancer of the oesophagus: The Cleveland clinic experience, Ann Surg, 203, pp. 101-108, (1986)
[8]  
Keeling P., Gillen P., Hennessy T.P., Oesophageal resection in the elderly, Ann R Coll Surg Engl, 70, pp. 34-36, (1988)
[9]  
Kucers A., Bennet N., Cefamandole, cefoxitin, cefuroxime and ceforanide, The use of antibiotics, pp. 267-293, (1979)
[10]  
Kucers A., Bennet N., Metronidazole, The use of antibiotics, pp. 761-781, (1979)